Clinical Trial: Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Pa
Brief Summary: This is an evaluation of celiac-specific patient reported outcome instruments in celiac disease patients.
Detailed Summary:
Sponsor: Alvine Pharmaceuticals Inc.
Current Primary Outcome: Change in symptoms using patient reported outcome instruments [ Time Frame: 8 and 12 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Safety - incidence of adverse events [ Time Frame: 8 and 12 weeks ]
Original Secondary Outcome: Same as current
Information By: Alvine Pharmaceuticals Inc.
Dates:
Date Received: March 20, 2012
Date Started: March 2012
Date Completion:
Last Updated: October 9, 2013
Last Verified: October 2013